Our current studies aim to:
- Produce large amounts of recombinant alpha and beta carbonic anhydrases (CAs) and carbonic anhydrase-related proteins (CARPs) for kinetic and structural studies.
- Study the role of CARPs in tissues.
- Continue our studies on tumor-associated CA isozymes, CA II, CA VII, CA IX, and CA XII.
- Develop in-silico tools for transcription factor binding site (TFBS) prediction and analysis.
- Study the role of beta carbonic anhydrases in parasitic organisms, with the goal of impacting human and animal health.
Seppo Parkkila MD PhD University of Tampere
School of Medicine, Department of Anatomy/Tissue Biology
Seppo Parkkila M.D., Ph.D. (born 1966) is a Professor of Anatomy at the University of Tampere, Finland (www.uta.fi). He graduated from the University of Oulu in 1991 (M.D.) and obtained his PhD in 1994 under supervision of Professor Hannu Rajaniemi. From 1996-1998 he worked as a visiting researcher in the laboratory of Professor William S. Sly at Saint Louis University. He became a specialist physician in Clinical Chemistry in 2001. In 2002 he moved to the University of Tampere where he was appointed to the post of Professor of Medical Technology and Biotechnology, and later in 2008 to the post of Professor of Anatomy. His research work focuses on pH-regulation, carbonic anhydrases and regulation of iron homeostasis. Professor Parkkila has published over 200 articles in international journals and has a wide network of research collaborators around the world. He has supervised 13 PhD theses and a number of MSc thesis projects. Professor Parkkila has been actively involved in university administrative bodies. He is currently a vice-chairman of the board of the School of Medicine in Tampere. He is also a director of the MD-PhD program at the School of Medicine. In addition to these academic responsibilities, Professor Parkkila also actively participates in the politics of his home country. During the spring 2015 he is a candidate in the parliamentary elections representing the National Coalition Party of Finland (http://seppoparkkila.fi).
Collaborators
BioMediTech, a joint institute of TUT and UTA, brings together a powerful mix of multidisciplinary expertise in life sciences and medical technology. Over 250 scientists conduct research and education in the fields of cell and molecular biology, genetics, biomaterials, biosensors, computational systems, biotechnology, biomedical engineering, and regenerative medicine.
We are Finland’s largest laboratory company and we produce health laboratory services in Pirkanmaa and Kanta-Häme total of more than 60 offices around 600 professionals.
Group Skills
Follow Us